| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/29/2004 | CN1557356A Black soya bean oil contained compound gelling agent |
| 12/29/2004 | CN1557354A Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process |
| 12/29/2004 | CN1557353A Preparing and quality controlling method of Chinese traditional medicine composition |
| 12/29/2004 | CN1557349A Pill of antelope horn and pearl powder for treating eye disease |
| 12/29/2004 | CN1557347A Medicine for treating cardiac and cerebral vascular diseases and its preparation |
| 12/29/2004 | CN1557346A Whole gastrodia tuber dripping pills and its preparing process |
| 12/29/2004 | CN1557342A Antisenescent and sexual function improving preparation |
| 12/29/2004 | CN1557341A Preparing process of multiple biologically active substance containing formulation |
| 12/29/2004 | CN1557331A Oral prescription of cytidine triphosphate |
| 12/29/2004 | CN1557330A Sustained release medication of clindamycinum |
| 12/29/2004 | CN1557326A Whelk treating medicine composition and its preparation method |
| 12/29/2004 | CN1557323A Diammonium glycyrrhizinate powder injection and its preparation method |
| 12/29/2004 | CN1557320A Meloxicam containing skin topical paste formulation |
| 12/29/2004 | CN1557319A Rosuvastatin dispersion tablet and its preparation method |
| 12/29/2004 | CN1557318A Continuous release medicine composition and its preparation method |
| 12/29/2004 | CN1557316A Enoxacin Glyconate large volume injection and its preparation method |
| 12/29/2004 | CN1557315A Baloxin water-soluble salt and its injection formulation |
| 12/29/2004 | CN1557314A Prulifloxacin water-soluble salt and its injection formulation |
| 12/29/2004 | CN1557312A Rheumatism soft capsule and its preparation method |
| 12/29/2004 | CN1557311A Fibrauretine capsule tablet and its preparation method |
| 12/29/2004 | CN1557310A Sinlmenine hydrochloride plaster and its preparation method |
| 12/29/2004 | CN1557309A Amlodipine dispersion tablet and its preparation method |
| 12/29/2004 | CN1557308A Tiotropium aerosol inhalant and its preparation method |
| 12/29/2004 | CN1557306A Flavescent sophora root essence dispersion tablet |
| 12/29/2004 | CN1557305A Matrine drop pills and its preparation method |
| 12/29/2004 | CN1557302A Carbazochrome Sodium Sulfonate infusion and its preparation method |
| 12/29/2004 | CN1557299A Injectio Natarii Norcantharidatis infusion and its preparation method |
| 12/29/2004 | CN1557298A Injectio Natarii Norcantharidatis freeze-drying powder injection and its preparation method |
| 12/29/2004 | CN1557297A Gingko lactone powder injection and its preparation method |
| 12/29/2004 | CN1557296A Gingko lactone freeze dried powder injection and its preparation method |
| 12/29/2004 | CN1557295A Gynecopathy therapeutic drug |
| 12/29/2004 | CN1557294A Oryzanol containing soft capsule preparation method |
| 12/29/2004 | CN1557293A Brufen arginine pseudoephedrine hydrochloride compound formulation |
| 12/29/2004 | CN1557291A Nateglinide dispersant tablet and its preparation method |
| 12/29/2004 | CN1557290A Compound diclofenac Potassium injection liquid formulation |
| 12/29/2004 | CN1557289A Tensicor freeze-drying formulation and its making method |
| 12/29/2004 | CN1557288A Lactic acid , glycerin formulation for female vagina acidity, humidity improvement |
| 12/29/2004 | CN1557286A Compound chlorhexidine acetate spray |
| 12/29/2004 | CN1557285A Bromhexine Hydrochloride aseptic freeze-drying formulation for injection and its preparation method |
| 12/29/2004 | CN1557284A Biological spray for snoring relieve |
| 12/29/2004 | CN1557283A Ternary composite microsphere formulation and its preparation method |
| 12/29/2004 | CN1557282A Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method |
| 12/29/2004 | CN1182219C Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 12/29/2004 | CN1181896C Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
| 12/29/2004 | CN1181889C Process for preparing oral insulin nano material |
| 12/29/2004 | CN1181888C Stable recombination human alpha interferon liquid preparation and productive process thereof |
| 12/29/2004 | CN1181878C Externally applied Chinese medicinal powder for treating arthroncus |
| 12/29/2004 | CN1181871C Wolfs milk ointment and its preparation method |
| 12/29/2004 | CN1181865C Quick dissolving sensitive layer for treating gynecopathy |
| 12/29/2004 | CN1181864C Externally applied liquor for treating spondylopathy pain and its preparation |
| 12/29/2004 | CN1181862C Medicinal tablet for treating prostatitis and its preparing method |
| 12/29/2004 | CN1181832C Preparation of AIDS resisting medicine from indian stringbush root extract |
| 12/29/2004 | CN1181829C 吉西他滨溶液制剂 Gemcitabine solution formulation |
| 12/29/2004 | CN1181828C Notoginseng total saponin active element containing drop pills |
| 12/29/2004 | CN1181827C Oral drug delivery system for enhancing the bioavailability of activated glycyrrhizin |
| 12/29/2004 | CN1181824C Minocycline vaginal effervescent tablets |
| 12/29/2004 | CN1181821C Lesion-aimed antibiotics in dry dosage forms for treatment of shallow ulcers of oral mucosa |
| 12/29/2004 | CN1181820C Process for preparing miconazole nitrate ointment |
| 12/29/2004 | CN1181816C Swelling and deswelling polymer blends |
| 12/29/2004 | CN1181815C Pharmaceutical preparation |
| 12/29/2004 | CN1181814C Fast oral dissolving films containing an ion exchange resin as a taste masking agent |
| 12/29/2004 | CN1181738C Therapeutic anti-fungal nail preparation |
| 12/29/2004 | CA2839930A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2839928A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2839898A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2839849A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2839847A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2673334A1 Oral extended-release composition |
| 12/29/2004 | CA2540695A1 Specific delivery of drugs to the brain |
| 12/29/2004 | CA2530736A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| 12/29/2004 | CA2530058A1 Mucin synthesis inhibitors |
| 12/29/2004 | CA2530003A1 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device |
| 12/29/2004 | CA2529963A1 Pharmaceutical compositions based on diclofenac derivate |
| 12/29/2004 | CA2529860A1 Ophthalmic composition |
| 12/29/2004 | CA2529852A1 Compositions for and methods for treating hiv |
| 12/29/2004 | CA2529503A1 Drug polymer complexes |
| 12/29/2004 | CA2529501A1 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 12/29/2004 | CA2529335A1 Granulated sucralose product |
| 12/29/2004 | CA2529287A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 12/29/2004 | CA2529268A1 Pharmaceutical formulations of amyloid inhibiting compounds |
| 12/29/2004 | CA2528899A1 Flupirtin injectable galenic form |
| 12/29/2004 | CA2528718A1 Treatment of amd with combination of ingredients |
| 12/29/2004 | CA2528313A1 Nail restructuring compositions for topical application |
| 12/29/2004 | CA2527712A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | CA2527417A1 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/29/2004 | CA2527091A1 Interferon gamma-like protein |
| 12/29/2004 | CA2526642A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 12/29/2004 | CA2526563A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 12/29/2004 | CA2526099A1 Freeze-dried fsh / lh formulations |
| 12/29/2004 | CA2524256A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/28/2004 | US6835722 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 12/28/2004 | US6835718 Biocleavable micelle compositions for use as drug carriers |
| 12/28/2004 | US6835717 Such as human immunodeficiency virus (HIV), herpes virus, Chlamydia spp., a Trichomona spp., or a Candida spp. |
| 12/28/2004 | US6835553 Photometric glucose measurement system using glucose-sensitive hydrogel |
| 12/28/2004 | US6835401 Method of treating diseases caused by over-production of free-radicals |
| 12/28/2004 | US6835396 Energizing a multiphase system having an organic phase containing a poorly water soluble compound, e.g. drug, and an aqueous phase to form a fine dispersion; freeze drying; particularly for intravenous injection |
| 12/28/2004 | US6835395 Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles |
| 12/28/2004 | US6835394 Semi-permeable, thin-walled, synthetic, super-amphiphilic block polymers that have a molecular weight of >1400 and self-assemble to vesicles without need for post-assembley polymerization or crosslinking |
| 12/28/2004 | US6835393 Enhanced transport using membrane disruptive agents |
| 12/28/2004 | US6835392 Dual enhancer composition for topical and transdermal drug delivery |